PPARG and diabetic kidney disease: BSA is commonly used as a control for evaluating the effect of AGEs in experimental researches such as in vitro study for diabetic nephropathy with cultured mesangial cells [5], and proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation [33].